For help on how to get the results you want, see our search tips.
1795 results
-
List item
Human medicine European public assessment report (EPAR): Onglyza (updated)
Saxagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 30/09/2009, Revision: 19, Authorised, Last updated: 16/04/2021 -
List item
Human medicine European public assessment report (EPAR): Jinarc (updated)
Tolvaptan, Polycystic Kidney, Autosomal Dominant
Date of authorisation: 27/05/2015,
, Revision: 15, Authorised, Last updated: 16/04/2021
-
List item
Human medicine European public assessment report (EPAR): DuoPlavin (updated)
clopidogrel, acetylsalicylic acid, Acute Coronary Syndrome, Myocardial Infarction
Date of authorisation: 14/03/2010, Revision: 24, Authorised, Last updated: 16/04/2021 -
List item
Human medicine European public assessment report (EPAR): Vaxzevria (previously COVID-19 Vaccine AstraZeneca) (updated)
ChAdOx1-SARS-COV-2, COVID-19 virus infection
Date of authorisation: 29/01/2021,, 
, Revision: 5, Authorised, Last updated: 16/04/2021
-
List item
Human medicine European public assessment report (EPAR): COVID-19 Vaccine Janssen (updated)
adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S), COVID-19 virus infection
Date of authorisation: 11/03/2021,, , Authorised, Last updated: 16/04/2021
-
List item
Human medicine European public assessment report (EPAR): Comirnaty (updated)
Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2, COVID-19 virus infection
Date of authorisation: 21/12/2020,, , Revision: 5, Authorised, Last updated: 16/04/2021
-
List item
Human medicine European public assessment report (EPAR): Edistride (updated)
dapagliflozin propanediol monohydrate, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1
Date of authorisation: 09/11/2015, Revision: 16, Authorised, Last updated: 15/04/2021 -
List item
Human medicine European public assessment report (EPAR): Zometa (updated)
zoledronic acid, zoledronic acid monohydrate, Cancer, Fractures, Bone
Date of authorisation: 20/03/2001, Revision: 35, Authorised, Last updated: 15/04/2021 -
List item
Human medicine European public assessment report (EPAR): ellaOne (updated)
ulipristal, Contraception, Postcoital
Date of authorisation: 15/05/2009, Revision: 22, Authorised, Last updated: 15/04/2021 -
List item
Human medicine European public assessment report (EPAR): Jevtana (updated)
cabazitaxel, Prostatic Neoplasms
Date of authorisation: 17/03/2011, Revision: 19, Authorised, Last updated: 15/04/2021 -
List item
Human medicine European public assessment report (EPAR): Oncaspar (updated)
pegaspargase, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 14/01/2016,, Revision: 13, Authorised, Last updated: 15/04/2021
-
List item
Human medicine European public assessment report (EPAR): Yondelis (updated)
trabectedin, Ovarian Neoplasms, Sarcoma
Date of authorisation: 17/09/2007, Revision: 26, Authorised, Last updated: 14/04/2021 -
List item
Human medicine European public assessment report (EPAR): Instanyl (updated)
Fentanyl citrate, Pain, Cancer
Date of authorisation: 20/07/2009, Revision: 28, Authorised, Last updated: 14/04/2021 -
List item
Human medicine European public assessment report (EPAR): Zercepac (updated)
trastuzumab, Breast Neoplasms, Stomach Neoplasms
Date of authorisation: 27/07/2020,, 
, Revision: 3, Authorised, Last updated: 14/04/2021
-
List item
Human medicine European public assessment report (EPAR): PecFent (updated)
fentanyl, Pain, Cancer
Date of authorisation: 31/08/2010, Revision: 20, Authorised, Last updated: 14/04/2021 -
List item
Human medicine European public assessment report (EPAR): Tenofovir disoproxil Zentiva (updated)
tenofovir disoproxil phosphate, HIV Infections
Date of authorisation: 15/09/2016,
, Revision: 9, Authorised, Last updated: 14/04/2021
-
List item
Human medicine European public assessment report (EPAR): Fotivda (updated)
tivozanib, Carcinoma, Renal Cell
Date of authorisation: 24/08/2017,, Revision: 5, Authorised, Last updated: 14/04/2021
-
List item
Human medicine European public assessment report (EPAR): Azacitidine Accord (updated)
azacitidine, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute
Date of authorisation: 13/02/2020,, Revision: 1, Authorised, Last updated: 14/04/2021
-
List item
Human medicine European public assessment report (EPAR): Effentora (updated)
fentanyl, Pain, Cancer
Date of authorisation: 04/04/2008, Revision: 23, Authorised, Last updated: 14/04/2021 -
List item
Human medicine European public assessment report (EPAR): Rukobia (updated)
fostemsavir trometamol, HIV Infections
Date of authorisation: 04/02/2021,, Revision: 1, Authorised, Last updated: 13/04/2021
-
List item
Human medicine European public assessment report (EPAR): Vantobra (previously Tobramycin PARI) (updated)
Tobramycin, Respiratory Tract Infections, Cystic Fibrosis
Date of authorisation: 18/02/2019, Revision: 3, Authorised, Last updated: 13/04/2021 -
List item
Human medicine European public assessment report (EPAR): Deferasirox Mylan (updated)
deferasirox, Iron Overload, beta-Thalassemia
Date of authorisation: 26/09/2019,, Revision: 4, Authorised, Last updated: 13/04/2021
-
List item
Human medicine European public assessment report (EPAR): Beromun (updated)
tasonermin, Sarcoma
Date of authorisation: 12/04/1999, Revision: 14, Authorised, Last updated: 13/04/2021 -
List item
Human medicine European public assessment report (EPAR): Synagis (updated)
palivizumab, Respiratory Syncytial Virus Infections
Date of authorisation: 13/08/1999, Revision: 42, Authorised, Last updated: 13/04/2021 -
List item
Human medicine European public assessment report (EPAR): Inovelon (updated)
Rufinamide, Epilepsy
Date of authorisation: 16/01/2007, Revision: 21, Authorised, Last updated: 12/04/2021